Prosecution Insights
Last updated: May 29, 2026

Examiner: WRIGHT, ERIC BRANDON

Tech Center 1600 • Art Units: 1632 1638 1651

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-60.0% vs TC avg
9
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
18.2%
§102 Novelty
18.2%
§103 Obviousness
36.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18605786 GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF Non-Final OA Indiana University Research and Technology Corporation
18508623 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MYELOID DERIVED SUPPRESSOR CELLS Non-Final OA Therapeutic Solutions International, Inc.
18504883 Optimized cell culture medium utilizing iron (III) citrate as an iron delivery method for the in vitro, bioreactor-centric production of manufactured blood Non-Final OA Sciperio, Inc
18094501 METHODS FOR TREATING ACUTE RESPIRATORY INFLAMMATORY CONDITIONS AND CYTOKINE STORM SYNDROME Non-Final OA REMEDY CELL LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month